Oral glucose retention, saliva viscosity and flow rate in 5-year-old children

M Negoro1, H Nakagaki, S Tsuboi

  • 1Department of Preventive Dentistry and Dental Public Health, School of Dentistry, Aichi-Gakuin University, 1-100 Kusumoto-cho, Chikusa-ku, 464-8650, Nagoya, Japan. nakagaki@dpc.aichi-gakuin.ac.jp

Archives of Oral Biology
|September 23, 2000
PubMed

Insights

Glucose retention in children

Area of Science:

  • Oral health
  • Biochemistry
  • Pediatric dentistry

Background:

  • Glucose retention varies significantly between individuals and specific oral sites.
  • Understanding these variations is crucial for assessing oral glucose metabolism and cariogenic potential.

Purpose of the Study:

  • To investigate the relationship between salivary viscosity, flow rate, and glucose retention in primary teeth.
  • To determine if glucose retention is site-specific within the oral cavity.

Main Methods:

  • Sixty-two 5-year-old schoolchildren participated.
  • Saliva samples were collected to determine flow rate and viscosity using a rotational viscometer.
  • Glucose retention was measured 3 minutes after a 0.5 M glucose mouth rinse.

Main Results:

  • Glucose retention demonstrated site-specificity, with different correlations observed at primary molars and incisors.
  • A slight correlation was found between glucose retention, salivary viscosity, and flow rate.
  • A slight correlation was also noted between glucose retention and the decayed, missing, and filled primary teeth (dmft) index.

Conclusions:

  • Glucose retention following a glucose mouth rinse is site-specific in children.
  • Salivary characteristics (viscosity and flow rate) show a minor association with glucose retention and oral health status (dmft).

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Glucose Absorption Into the Small Intestine01:26

Glucose Absorption Into the Small Intestine

Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and 'exit' via the...
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...